$IBEX Balance Sheet | Understand Stock

$IBEX

$46.46 -$0.63 (1.34%) Live

$IBEX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Jun 30, 2026	Q3 FY2026 As of Mar 31, 2026	Q2 FY2026 As of Dec 31, 2025	Q1 FY2026 As of Sep 30, 2025	Q4 FY2025 As of Jun 30, 2025	Q3 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Dec 31, 2024	Q1 FY2025 As of Sep 30, 2024	Q4 FY2024 As of Jun 30, 2024	Q3 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Dec 31, 2023	Q1 FY2024 As of Sep 30, 2023	Q4 FY2023 As of Jun 30, 2023	Q4 FY2022 As of Jun 30, 2022	Q4 FY2021 As of Jun 30, 2021	Q4 FY2020 As of Jun 30, 2020
Cash and cash equivalents
Trade and other receivables
Due from related parties
Warrant asset
Total current assets
Property and equipment
Right of use assets
Goodwill
Other intangible assets
Investment in joint venture
Deferred tax asset
Other assets
Total non-current assets
Total assets
Trade and other payables
Deferred revenue
Lease liabilities
Borrowings
Due to related parties
Income tax payable
Total current liabilities
Non-current portion of deferred revenue
Deferred tax liability
Other non-current liabilities
Total non-current liabilities
Total liabilities
Share capital
Additional paid-in capital
Other reserves
Accumulated deficit
Total equity
Assets
Current assets
Cash and cash equivalents
Accounts receivable, net of allowance of $565 and $232
Prepaid expenses
Due from related parties
Tax advances and receivables
Other current assets
Total current assets
Non-current assets
Property and equipment, net
Operating lease assets
Goodwill
Deferred tax asset, net
Other non-current assets
Total non-current assets
Total assets
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued liabilities
Accrued payroll and employee-related liabilities
Current deferred revenue
Current operating lease liabilities
Convertible debt
Current debt
Due to related parties
Income taxes payable
Total current liabilities
Non-current liabilities
Non-current deferred revenue
Non-current operating lease liabilities
Long-term debt
Other non-current liabilities
Total non-current liabilities
Total liabilities
Stockholders' equity
Common shares: par value $0.000111650536, 108,057,967 shares authorized, 13,309,640 and 13,357,990 shares outstanding as of June 30, 2026 and 2025, respectively
Treasury shares at cost: 5,968,161 and 5,515,403 shares as of June 30, 2026 and 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Total stockholders' equity
Total liabilities and stockholders' equity

Comments